

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immun...
Q2 2026
Aug 4, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 19, 2026
Q4 2025
Feb 19, 2026
Q3 2025
Nov 4, 2025